Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
OmniLyte is a biotechnology company specializing in the development and application of electrolyzed water technology for pathogen control and biosecurity. The company utilizes the Envirolyte platform to produce Hypochlorous Acid (HOCl), a powerful, non-toxic antimicrobial solution known as Anolyte. OmniLyte's systems are primarily deployed in the animal health, agriculture, and food processing industries to provide sustainable alternatives to traditional chemical disinfectants. Their technology effectively eliminates a broad spectrum of bacteria, viruses, and spores while remaining safe for human and animal contact. In addition to providing on-site generation equipment, the company offers specialized solutions for water treatment and surface disinfection. OmniLyte's focus on eco-friendly biosecurity helps industries maintain high hygiene standards and reduce environmental impact.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on OmniLyte.